177Lutetium-octreotate can improve progression-free survival vs sunitinib in patients with progressive pancreatic neuroendocrine tumors.
All articles by Vicki Moore, PhD
Researchers sought to determine whether there were negative impacts on bone health for patients receiving chemotherapy treatment for lymphoma.
Researchers sought to determine the fertility-related issues and approaches for survivors of Hodgkin lymphoma and diffuse large B-cell lymphoma.
Results of the phase 2 MALE clinical trial comparing 3 treatment regimens in men with hormone-receptor positive breast cancer are reported.
Researchers sought to identify and analyze risk factors for thrombosis in adolescent girls receiving hormonal therapy.